| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Warren Lucinda | CHIEF BUSINESS OFFICER | C/O CUE BIOPHARMA, INC., 40 GUEST STREET, BOSTON | /s/ Lucinda Warren | 25 Nov 2025 | 0002035620 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CUE | Stock Option (right to buy) | Award | $0 | +125,000 | $0.000000 | 125,000 | 29 Sep 2025 | Common Stock | 125,000 | $0.7200 | Direct | F1 |
| Id | Content |
|---|---|
| F1 | This stock option becomes fully exercisable on the first anniversary of the grant date. |